National Health (Pharmaceutical Benefits—Early Supply) Specification 2026
8Circumstances relating to specification of pharmaceutical items in Schedule 2
Start here
Get a plain-English read of 8
Turn the raw legal text into a practical explanation grounded in National Health (Pharmaceutical Benefits—Early Supply) Specification 2026.
8 Circumstances relating to specification of pharmaceutical items in Schedule 2
For paragraph 6(3)(b), the circumstances in relation to a pharmaceutical benefit are:
(a) the supply of the benefit is made on the basis of a prescription; and
(b) the supply was not made under subsection 89A(1) of the Act; and
(c) the prescription must have been written:
(i) for a purpose for which the maximum quantity or number of units specified in the column headed ‘Maximum quantity or number of units’ in an item in Schedule 2 for the pharmaceutical item was determined under paragraph 85A(2)(a) of the Act; and
(ii) for a purpose for which the maximum number of repeats specified in the column headed ‘Maximum number of repeats’ specified in the same table item in Schedule 2 for the pharmaceutical benefit was determined under paragraph 85A(2)(b) of the Act; and
(d) any other circumstance for paragraph 84AAA(3)(b) of the Act that is mentioned in the table in Schedule 2 for the benefit.